Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897078 · ClinicalTrials.gov registry record
Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 39
- Enrollment target
NCT00897078: Completed study, sponsored by Vanderbilt University.
NCT00897078 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897078 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about metabolic syndrome from young patients who have survived acute lymphoblastic leukemia (ALL) may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients who have survived acute lymphoblastic leukemia and in healthy sibling volunteers.
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- OTHER questionnaire administration
- PROCEDURE assessment of therapy complications
- OTHER metabolic assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-10 |
What the finished NCT00897078 record still lists
NCT00897078 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00897078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897078 about?
NCT00897078 is a clinical study titled "Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings". RATIONALE: Gathering information about metabolic syndrome from young patients who have survived acute lymphoblastic leukemia (ALL) may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients who have survived acute lymphoblastic le...
What is the current status of trial NCT00897078?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2009-01. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00897078?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), questionnaire administration (OTHER), assessment of therapy complications (PROCEDURE), metabolic assessment (OTHER).
Who is sponsoring clinical trial NCT00897078?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia